Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 32,318Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 6APOTEX INC

02 6BRISTOL-MYERS SQUIBB CANADA

03 6JAMP PHARMA CORPORATION

04 6NATCO PHARMA (CANADA) INC

05 6SANDOZ CANADA INCORPORATED

06 6TARO PHARMACEUTICALS INC

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

Paris Packaging Week
Not Confirmed
arrow
arrow
Paris Packaging Week
Not Confirmed

LENALIDOMIDE

Brand Name : REVLIMID

Dosage Form : CAPSULE

Dosage Strength : 5MG

Packaging : 100

Approval Date :

Application Number : 2304899

Regulatory Info : Prescription

Registration Country : Canada

blank

02

Paris Packaging Week
Not Confirmed
arrow
arrow
Paris Packaging Week
Not Confirmed

LENALIDOMIDE

Brand Name : REVLIMID

Dosage Form : CAPSULE

Dosage Strength : 10MG

Packaging : 100

Approval Date :

Application Number : 2304902

Regulatory Info : Prescription

Registration Country : Canada

blank

03

Paris Packaging Week
Not Confirmed
arrow
arrow
Paris Packaging Week
Not Confirmed

LENALIDOMIDE

Brand Name : REVLIMID

Dosage Form : CAPSULE

Dosage Strength : 15MG

Packaging :

Approval Date :

Application Number : 2317699

Regulatory Info : Prescription

Registration Country : Canada

blank

04

Paris Packaging Week
Not Confirmed
arrow
arrow
Paris Packaging Week
Not Confirmed

LENALIDOMIDE

Brand Name : REVLIMID

Dosage Form : CAPSULE

Dosage Strength : 25MG

Packaging : 100

Approval Date :

Application Number : 2317710

Regulatory Info : Prescription

Registration Country : Canada

blank

05

Paris Packaging Week
Not Confirmed
arrow
arrow
Paris Packaging Week
Not Confirmed

LENALIDOMIDE

Brand Name : REVLIMID

Dosage Form : CAPSULE

Dosage Strength : 20MG

Packaging :

Approval Date :

Application Number : 2440601

Regulatory Info : Prescription

Registration Country : Canada

blank

06

Paris Packaging Week
Not Confirmed
arrow
arrow
Paris Packaging Week
Not Confirmed

LENALIDOMIDE

Brand Name : REVLIMID

Dosage Form : CAPSULE

Dosage Strength : 2.5MG

Packaging : 21

Approval Date :

Application Number : 2459418

Regulatory Info : Prescription

Registration Country : Canada

blank

07

PharmaSynergy
Not Confirmed
arrow
arrow
PharmaSynergy
Not Confirmed

LENALIDOMIDE

Brand Name : NAT-LENALIDOMIDE

Dosage Form : CAPSULE

Dosage Strength : 2.5MG

Packaging :

Approval Date :

Application Number : 2493837

Regulatory Info : Prescription

Registration Country : Canada

blank

08

Paris Packaging Week
Not Confirmed
arrow
arrow
Paris Packaging Week
Not Confirmed

LENALIDOMIDE

Brand Name : NAT-LENALIDOMIDE

Dosage Form : CAPSULE

Dosage Strength : 5MG

Packaging :

Approval Date :

Application Number : 2493845

Regulatory Info : Prescription

Registration Country : Canada

blank

09

Paris Packaging Week
Not Confirmed
arrow
arrow
Paris Packaging Week
Not Confirmed

LENALIDOMIDE

Brand Name : NAT-LENALIDOMIDE

Dosage Form : CAPSULE

Dosage Strength : 10MG

Packaging :

Approval Date :

Application Number : 2493861

Regulatory Info : Prescription

Registration Country : Canada

blank

10

Paris Packaging Week
Not Confirmed
arrow
arrow
Paris Packaging Week
Not Confirmed

LENALIDOMIDE

Brand Name : NAT-LENALIDOMIDE

Dosage Form : CAPSULE

Dosage Strength : 15MG

Packaging :

Approval Date :

Application Number : 2493888

Regulatory Info : Prescription

Registration Country : Canada

blank